Selected research
Industry Research
Computer-Aided Drug Industry Research Report 2026
Market perspective
The global Computer-Aided Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Computer-Aided Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Computer-Aided Drug market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Computer-Aided Drug market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Computer-Aided Drug include Aaranya Biosciences Pvt. Ltd., Albany Molecular Research Inc., Charles River Laboratories International Inc., Chembio Discovery Inc., Chemical Computing Group ULC, Compchem Solutions Ltd., International Business Machines Corp., Kang Yusheng Information Technology Co. Ltd. and Market Positioning Of Vendors, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Computer-Aided Drug market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Computer-Aided Drug.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Computer-Aided Drug Market by Company
Aaranya Biosciences Pvt. Ltd.
Albany Molecular Research Inc.
Charles River Laboratories International Inc.
Chembio Discovery Inc.
Chemical Computing Group ULC
Compchem Solutions Ltd.
International Business Machines Corp.
Kang Yusheng Information Technology Co. Ltd.
Market Positioning Of Vendors
Openeye Scientific Software Inc.
Pharmaron Beijing Co. Ltd.
Computer-Aided Drug Segment by Type
Structure Based Drug
Ligand Based Drug
Computer-Aided Drug Segment by Application
Oncological Disorders
Neurological Disorders
Other
Computer-Aided Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computer-Aided Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Computer-Aided Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computer-Aided Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Computer-Aided Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Structure Based Drug
- Ligand Based Drug
Applications
- Oncological Disorders
- Neurological Disorders
- Other
Companies covered
- Aaranya Biosciences Pvt. Ltd.
- Albany Molecular Research Inc.
- Charles River Laboratories International Inc.
- Chembio Discovery Inc.
- Chemical Computing Group ULC
- Compchem Solutions Ltd.
- International Business Machines Corp.
- Kang Yusheng Information Technology Co. Ltd.
- Market Positioning Of Vendors
- Openeye Scientific Software Inc.
- Pharmaron Beijing Co. Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Computer-Aided Drug by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Structure Based Drug
- 2.2.3 Ligand Based Drug
- 2.3 Computer-Aided Drug by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Oncological Disorders
- 2.3.3 Neurological Disorders
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Computer-Aided Drug Breakdown Data by Type
- 3.1 Global Computer-Aided Drug Historic Market Size by Type (2021-2026)
- 3.2 Global Computer-Aided Drug Forecasted Market Size by Type (2027-2032)
4 Computer-Aided Drug Breakdown Data by Application
- 4.1 Global Computer-Aided Drug Historic Market Size by Application (2021-2026)
- 4.2 Global Computer-Aided Drug Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Computer-Aided Drug Market Perspective (2021-2032)
- 5.2 Global Computer-Aided Drug Growth Trends by Region
- 5.2.1 Global Computer-Aided Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Computer-Aided Drug Historic Market Size by Region (2021-2026)
- 5.2.3 Computer-Aided Drug Forecasted Market Size by Region (2027-2032)
- 5.3 Computer-Aided Drug Market Dynamics
- 5.3.1 Computer-Aided Drug Industry Trends
- 5.3.2 Computer-Aided Drug Market Drivers
- 5.3.3 Computer-Aided Drug Market Challenges
- 5.3.4 Computer-Aided Drug Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Computer-Aided Drug Players by Revenue
- 6.1.1 Global Top Computer-Aided Drug Players by Revenue (2021-2026)
- 6.1.2 Global Computer-Aided Drug Revenue Market Share by Players (2021-2026)
- 6.2 Global Computer-Aided Drug Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Computer-Aided Drug Head Office and Area Served
- 6.4 Global Computer-Aided Drug Players, Product Type & Application
- 6.5 Global Computer-Aided Drug Manufacturers Established Date
- 6.6 Global Computer-Aided Drug Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Computer-Aided Drug Market Size (2021-2032)
- 7.2 North America Computer-Aided Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Computer-Aided Drug Market Size by Country (2021-2026)
- 7.4 North America Computer-Aided Drug Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Computer-Aided Drug Market Size (2021-2032)
- 8.2 Europe Computer-Aided Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Computer-Aided Drug Market Size by Country (2021-2026)
- 8.4 Europe Computer-Aided Drug Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Computer-Aided Drug Market Size (2021-2032)
- 9.2 Asia-Pacific Computer-Aided Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Computer-Aided Drug Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Computer-Aided Drug Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Computer-Aided Drug Market Size (2021-2032)
- 10.2 South America Computer-Aided Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Computer-Aided Drug Market Size by Country (2021-2026)
- 10.4 South America Computer-Aided Drug Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Computer-Aided Drug Market Size (2021-2032)
- 11.2 Middle East & Africa Computer-Aided Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Computer-Aided Drug Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Computer-Aided Drug Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Aaranya Biosciences Pvt. Ltd.
- 12.1.1 Aaranya Biosciences Pvt. Ltd. Company Information
- 12.1.2 Aaranya Biosciences Pvt. Ltd. Business Overview
- 12.1.3 Aaranya Biosciences Pvt. Ltd. Revenue in Computer-Aided Drug Business (2021-2026)
- 12.1.4 Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Product Portfolio
- 12.1.5 Aaranya Biosciences Pvt. Ltd. Recent Developments
- 12.2 Albany Molecular Research Inc.
- 12.2.1 Albany Molecular Research Inc. Company Information
- 12.2.2 Albany Molecular Research Inc. Business Overview
- 12.2.3 Albany Molecular Research Inc. Revenue in Computer-Aided Drug Business (2021-2026)
- 12.2.4 Albany Molecular Research Inc. Computer-Aided Drug Product Portfolio
- 12.2.5 Albany Molecular Research Inc. Recent Developments
- 12.3 Charles River Laboratories International Inc.
- 12.3.1 Charles River Laboratories International Inc. Company Information
- 12.3.2 Charles River Laboratories International Inc. Business Overview
- 12.3.3 Charles River Laboratories International Inc. Revenue in Computer-Aided Drug Business (2021-2026)
- 12.3.4 Charles River Laboratories International Inc. Computer-Aided Drug Product Portfolio
- 12.3.5 Charles River Laboratories International Inc. Recent Developments
- 12.4 Chembio Discovery Inc.
- 12.4.1 Chembio Discovery Inc. Company Information
- 12.4.2 Chembio Discovery Inc. Business Overview
- 12.4.3 Chembio Discovery Inc. Revenue in Computer-Aided Drug Business (2021-2026)
- 12.4.4 Chembio Discovery Inc. Computer-Aided Drug Product Portfolio
- 12.4.5 Chembio Discovery Inc. Recent Developments
- 12.5 Chemical Computing Group ULC
- 12.5.1 Chemical Computing Group ULC Company Information
- 12.5.2 Chemical Computing Group ULC Business Overview
- 12.5.3 Chemical Computing Group ULC Revenue in Computer-Aided Drug Business (2021-2026)
- 12.5.4 Chemical Computing Group ULC Computer-Aided Drug Product Portfolio
- 12.5.5 Chemical Computing Group ULC Recent Developments
- 12.6 Compchem Solutions Ltd.
- 12.6.1 Compchem Solutions Ltd. Company Information
- 12.6.2 Compchem Solutions Ltd. Business Overview
- 12.6.3 Compchem Solutions Ltd. Revenue in Computer-Aided Drug Business (2021-2026)
- 12.6.4 Compchem Solutions Ltd. Computer-Aided Drug Product Portfolio
- 12.6.5 Compchem Solutions Ltd. Recent Developments
- 12.7 International Business Machines Corp.
- 12.7.1 International Business Machines Corp. Company Information
- 12.7.2 International Business Machines Corp. Business Overview
- 12.7.3 International Business Machines Corp. Revenue in Computer-Aided Drug Business (2021-2026)
- 12.7.4 International Business Machines Corp. Computer-Aided Drug Product Portfolio
- 12.7.5 International Business Machines Corp. Recent Developments
- 12.8 Kang Yusheng Information Technology Co. Ltd.
- 12.8.1 Kang Yusheng Information Technology Co. Ltd. Company Information
- 12.8.2 Kang Yusheng Information Technology Co. Ltd. Business Overview
- 12.8.3 Kang Yusheng Information Technology Co. Ltd. Revenue in Computer-Aided Drug Business (2021-2026)
- 12.8.4 Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Product Portfolio
- 12.8.5 Kang Yusheng Information Technology Co. Ltd. Recent Developments
- 12.9 Market Positioning Of Vendors
- 12.9.1 Market Positioning Of Vendors Company Information
- 12.9.2 Market Positioning Of Vendors Business Overview
- 12.9.3 Market Positioning Of Vendors Revenue in Computer-Aided Drug Business (2021-2026)
- 12.9.4 Market Positioning Of Vendors Computer-Aided Drug Product Portfolio
- 12.9.5 Market Positioning Of Vendors Recent Developments
- 12.10 Openeye Scientific Software Inc.
- 12.10.1 Openeye Scientific Software Inc. Company Information
- 12.10.2 Openeye Scientific Software Inc. Business Overview
- 12.10.3 Openeye Scientific Software Inc. Revenue in Computer-Aided Drug Business (2021-2026)
- 12.10.4 Openeye Scientific Software Inc. Computer-Aided Drug Product Portfolio
- 12.10.5 Openeye Scientific Software Inc. Recent Developments
- 12.11 Pharmaron Beijing Co. Ltd.
- 12.11.1 Pharmaron Beijing Co. Ltd. Company Information
- 12.11.2 Pharmaron Beijing Co. Ltd. Business Overview
- 12.11.3 Pharmaron Beijing Co. Ltd. Revenue in Computer-Aided Drug Business (2021-2026)
- 12.11.4 Pharmaron Beijing Co. Ltd. Computer-Aided Drug Product Portfolio
- 12.11.5 Pharmaron Beijing Co. Ltd. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst